Golimumab
Showing 1 - 25 of 161
Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)
Not yet recruiting
- Psoriatic Arthritis
- Guselkumab
- +2 more
-
Philadelphia, PennsylvaniaHospital at the University of Pennsylvania
Dec 20, 2022
Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)
Not yet recruiting
- Psoriatic Arthritis
- Guselkumab
- Golimumab
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 18, 2022
Axial Spondyloarthritis Trial in Bonheiden, Ghent, Hasselt (Golimumab)
Recruiting
- Axial Spondyloarthritis
- Golimumab
-
Bonheiden, Antwerpen, Belgium
- +2 more
Nov 30, 2022
Golimumab in Ulcerative Colitis: Results ofReal-life Study in
Completed
- Ulcerative Colitis
- Flare Up, Symptom
- Exposure to golimumab
-
Zurich, SwitzerlandDivision of Gastroenterology, University Hospital Zurich
May 31, 2022
Diabetes, Type 1 Trial in San Diego (Golimumab)
Available
- Diabetes Mellitus, Type 1
- Golimumab
-
San Diego, CaliforniaRady Children's Hospital
Jul 28, 2022
Rheumatoid Arthritis Trial in Plovdiv (AVT05 (proposed biosimilar to golimumab), Simponi (Golimumab))
Recruiting
- Rheumatoid Arthritis
- AVT05 (proposed biosimilar to golimumab)
- Simponi (Golimumab)
-
Plovdiv, BulgariaRheumatology clinic, University Multiprofile Hospital for Active
Apr 24, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)
Active, not recruiting
- Arthritis, Juvenile
- Golimumab
- Methotrexate
-
San Diego, California
- +37 more
Jan 17, 2023
Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis
Completed
- JIA Associated Uveitis
- Golimumab
- (no location specified)
Sep 1, 2021
Golimumab Trough Levels in Patients With Ulcerative Colitis
Completed
- Ulcerative Colitis
- Golimumab trough levels
- +3 more
-
Alcorcón, Madrid, Spain
- +11 more
Apr 13, 2022
Modulation of Gut Microbiota in Ulcerative Colitis
Completed
- Ulcerative Colitis
- Golimumab
-
Girona, Catalonia, SpainHospital Doctor Josep Trueta
Jun 28, 2021
Healthy Adult Subjects Trial in Christchurch (AVT05, Simponi)
Recruiting
- Healthy Adult Subjects
- AVT05
- Simponi
-
Christchurch, New ZealandNew Zealand Clinical Research
Jan 13, 2023
Ulcerative Colitis Trial in London (Golimumab)
Completed
- Ulcerative Colitis
- Golimumab
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Jul 2, 2021
Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)
Recruiting
- Axial Spondyloarthritis
- Tapered doses of TNFi
- Standard dose of TNFi
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto Western Hospital
Nov 21, 2022
Pre-Symptomatic Type 1 Diabetes Trial in Finland, Sweden, United States (Golimumab, Placebo)
Completed
- Pre-Symptomatic Type 1 Diabetes
- Golimumab
- Placebo
-
Aurora, Colorado
- +7 more
Sep 9, 2021
TofAcitinib in Routine Care Rheumatoid Arthritis-Cancer
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Jun 17, 2022
Rheumatoid Arthritis Trial in Abu Dhabi (Anti-TNF, JAK inhibitor)
Not yet recruiting
- Rheumatoid Arthritis
- Anti-TNF
- JAK inhibitor
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
May 17, 2022
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Mar 1, 2022
ULCERATIVE COLITIS Trial in Belgium, France (GOLIMUMAB)
Active, not recruiting
- ULCERATIVE COLITIS
- GOLIMUMAB
-
Liege, Belgium
- +22 more
Jun 28, 2021
Diabetes, Type 1 Trial (Golimumab, Placebo)
Withdrawn
- Diabetes Mellitus, Type 1
- Golimumab
- Placebo
- (no location specified)
Nov 19, 2021
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022